首页> 外文会议>Conference on Cognitive Sciences, Genomics and Bioinformatics >Mutational profile of Diffuse Large B-cell Lymphoma with central nervous system relapse: analysis of CBioPortal for Cancer Genomics database
【24h】

Mutational profile of Diffuse Large B-cell Lymphoma with central nervous system relapse: analysis of CBioPortal for Cancer Genomics database

机译:弥漫性大B细胞淋巴瘤与中枢神经系统复发的突变特征:用于癌症基因组学数据库的CBioPortal分析

获取原文

摘要

In this study, based on the information presented in the specialized resource CBioPortal for Cancer Genomics database, the data on the diffuse large B-cell lymphoma (DLBCL) mutation profile detected by next generation sequencing (NGS) methods have been analyzed. The features associated with a high risk of secondary central nervous system (CNS) involvement have been highlighted. In patients with DLBCL and secondary CNS involvement, the most frequently mutated genes were MYD88, PIM1, CARD11 and CD79B. These genes related to the BCR/NF-kB signaling pathway. The MYD88, PIM1 and CD79B genes mutations were often combined and, in total, occurred in 39.6% of cases in patients with CNS relapsed DLBCL.
机译:在这项研究中,基于专门用于癌症基因组学的资源CBioPortal数据库中提供的信息,对通过下一代测序(NGS)方法检测到的弥漫性大B细胞淋巴瘤(DLBCL)突变谱数据进行了分析。与继发性中枢神经系统(CNS)受累的高风险相关的功能已得到强调。在患有DLBCL和继发中枢神经系统受累的患者中,最常见的突变基因是MYD88,PIM1,CARD11和CD79B。这些基因与BCR / NF-kB信号通路有关。 MYD88,PIM1和CD79B基因突变经常合并在一起,在CNS复发性DLBCL患者中,总共发生39.6%的病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号